Hongbin Gao Selected Research

Luciferases

1/2021

Downregulation of PART1 Inhibits Proliferation and Differentiation of Hep3B Cells by Targeting hsa-miR-3529-3p/FOXC2 Axis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hongbin Gao Research Topics

Disease

6	Neoplasms (Cancer) 05/2022 - 01/2018
2	Urinary Bladder Neoplasms (Bladder Cancer) 04/2024 - 01/2022
2	COVID-19 12/2022 - 01/2020
2	Craniofacial Dysostosis (Crouzon Disease) 11/2017 - 09/2016
2	Craniosynostoses (Craniosynostosis) 10/2017 - 09/2016
2	Vitelliform Macular Dystrophy 10/2017 - 08/2015
2	Nephrolithiasis 03/2017 - 08/2013
2	Kidney Calculi (Kidney Stone) 05/2015 - 08/2013
1	Soft Tissue Injuries (Soft Tissue Injury) 01/2024
1	Cicatrix (Scar) 01/2024
1	Wounds and Injuries (Trauma) 01/2024
1	Leukemia 12/2023
1	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2023
1	Hepatocellular Carcinoma (Hepatoma) 03/2022
1	Myocardial Infarction 01/2022
1	Necrosis 01/2022
1	Carcinoma (Carcinomatosis) 01/2022
1	Carcinogenesis 01/2022
1	Liver Diseases (Liver Disease) 01/2022
1	Inflammation (Inflammations) 01/2022
1	Liver Neoplasms (Liver Cancer) 01/2021
1	Infections 01/2020
1	Melanoma (Melanoma, Malignant) 01/2019
1	Fibrosis (Cirrhosis) 01/2019
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Infarction (Infarctions) 01/2019
1	Phototoxic Dermatitis (Phototoxicity) 04/2018
1	Familial Exudative Vitreoretinopathies 02/2018
1	Contact Dermatitis (Eczema, Contact) 02/2018
1	Urinary Calculi (Urinary Calculus) 03/2017
1	Urolithiasis 03/2017
1	Hypercalciuria 03/2017
1	Exophthalmos (Proptosis) 09/2016
1	Hypokalemia 05/2013
1	Poisoning 05/2013

Drug/Important Bio-Agent (IBA)

3	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 11/2017 - 09/2016
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2024 - 11/2023
2	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2019
2	Long Noncoding RNAIBA 01/2022 - 01/2021
2	BestrophinsIBA 10/2017 - 08/2015
2	Adenosine Triphosphatases (ATPase)IBA 05/2015 - 08/2013
2	trimethyltinIBA 05/2015 - 08/2013
1	Cisplatin (Platino)FDA LinkGeneric 04/2024
1	Tetradecanoylphorbol AcetateIBA 12/2023
1	Glycoproteins (Glycoprotein)IBA 11/2023
1	VaccinesIBA 12/2022
1	SARS-CoV-2 spike proteinIBA 12/2022
1	LipidsIBA 05/2022
1	amidaseIBA 05/2022
1	AmidesIBA 05/2022
1	PolymersIBA 05/2022
1	EnzymesIBA 05/2022
1	Cytochrome P-450 CYP3A InhibitorsIBA 03/2022
1	2,2',4,4'-tetrabromodiphenyl etherIBA 03/2022
1	4,4'-hexafluorisopropylidene diphenolIBA 03/2022
1	Ethanol (Ethyl Alcohol)IBA 03/2022
1	Ketoconazole (Nizoral)FDA LinkGeneric 03/2022
1	Rifampin (Rifampicin)FDA LinkGeneric 03/2022
1	Cytochrome P-450 CYP2E1 (CYP2E1)IBA 03/2022
1	Cytochrome P-450 CYP3AIBA 03/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	Organophosphonates (Phosphonates)IBA 08/2021
1	Drug CarriersIBA 08/2021
1	Phosphates (Orthophosphate)IBA 08/2021
1	Phosphorus (Red Phosphorus)IBA 08/2021
1	LuciferasesIBA 01/2021
1	AndrogensIBA 01/2021
1	FurinIBA 01/2020
1	CollagenIBA 01/2019
1	Lipoproteins (Lipoprotein)IBA 01/2019
1	FluoroquinolonesIBA 04/2018
1	Toll-Like Receptor 4IBA 02/2018
1	Retinaldehyde (Retinal)IBA 02/2018
1	ElementsIBA 01/2018
1	Vitamin D FDA LinkGeneric 03/2017
1	hydroxide ionIBA 03/2017
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 09/2016
1	trimethyltin chlorideIBA 05/2015
1	StruviteIBA 05/2015
1	Drinking WaterIBA 05/2015
1	CalciumIBA 05/2015
1	PlasticsIBA 08/2013
1	ORALIT (ORS)IBA 08/2013
1	Polyvinyl Chloride (PVC)IBA 05/2013
1	methyltinIBA 05/2013

Therapy/Procedure

3	Therapeutics 05/2022 - 01/2019
1	Length of Stay 01/2024
1	Photothermal Therapy 05/2022
1	Drug Therapy (Chemotherapy) 05/2022
1	Oral Administration 01/2022
1	Immunomodulation 08/2021
1	Immunotherapy 08/2021
1	Warm Ischemia 01/2018
1	Nephrectomy 01/2018
1	Operative Time 01/2018